Orient Europharma Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 10, 2020 at 05:18 am IST
Share
Orient EuroPharma Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 1,344.501 million compared to TWD 1,519.476 million a year ago. Operating income was TWD 99.474 million compared to TWD 90.063 million a year ago. Net income was TWD 128.270 million compared to TWD 53.498 million a year ago. Basic earnings per share was TWD 1.48 compared to TWD 0.62 a year ago. For the half year, sales was TWD 2,894.460 million compared to TWD 3,021.653 million a year ago. Operating income was TWD 311.071 million compared to TWD 224.988 million a year ago. Net income was TWD 246.311 million compared to TWD 183.304 million a year ago. Basic earnings per share was TWD 2.84 compared to TWD 2.11 a year ago. Diluted earnings per share was TWD 2.83 compared to TWD 2.11 a year ago.
Orient Europharma Co., Ltd. is principally engaged in the manufacture and distribution of nutritious healthcare products and medical cosmetic products, as well as western drugs. The Company operates nutritious healthcare products and medical cosmetic products segment, providing infant milk powders, nutritious products and functional healthcare products, as well as dermatological preparations, medical hair care series, organic skin care series and medical make-up products, among others; western drugs segment, providing products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases and asthma, among others.
ORIENT EUROPHARMA CO., LTD. 
